DCDC2: Demystifying and Decoding DyslexiaTuesday, Feb 28, 2006
A recent study shows that variations in a gene called DCDC2 may disrupt the normal formation of brain circuits that are necessary
for fluent reading, leading to dyslexia. After further research, genetic screening for these variations could identify affected
children early in their lives and possibly prevent the misdiagnosis of other learning disabilities that resemble dyslexia.
Researchers Identify Potential Treatment for Learning Disability in NeurofibromatosisWednesday, Jan 16, 2002
Researchers studying learning disabilities associated with neurofibromatosis type 1, or NF1, have traced the problem to excessive
activity of a crucial signaling molecule and have successfully reversed the disabilities in mice by giving them an experimental
drug. The findings provide hope that these learning problems may one day be treatable in humans.
Fact Sheet Genetic Analysis of Childhood Brain Tumors Improves Diagnosis And Predicts SurvivalFriday, Mar 8, 2002
Doctors who treat brain tumors and other kinds of cancer have long struggled to understand why some patients respond well
to therapy while others do not. In recent years, it has become clear that the answer lies at least partially in the genes.
Two studies now show that identifying the "genetic fingerprints" of some childhood brain tumors can greatly improve diagnosis
and predict patients' long-term survival. The findings help researchers understand how the tumors develop and may lead to
improved ways of treating them.
Fact Sheet Researchers Identify Potential Treatment for Learning Disability in NeurofibromatosisWednesday, Jan 16, 2002
Researchers studying learning disabilities associated with neurofibromatosis type 1, or NF1, have traced the problem to excessive
activity of a crucial signaling molecule and have successfully reversed the disabilities in mice by giving them an experimental
drug. The findings provide hope that these learning problems may one day be treatable in humans.
Fact Sheet